Cargando…
Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
PURPOSE: Gene-mediated enzyme replacement is a reasonable and highly promising approach for the treatment of Fabry disease (FD). The objective of the present study was to demonstrate the potential applications of solid lipid nanoparticle (SLN)-based nonviral vectors for the treatment of FD. METHODS:...
Autores principales: | Ruiz de Garibay, Aritz Pérez, Delgado, Diego, del Pozo-Rodríguez, Ana, Solinís, María Ángeles, Gascón, Alicia Rodríguez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484727/ https://www.ncbi.nlm.nih.gov/pubmed/23118528 http://dx.doi.org/10.2147/DDDT.S36131 |
Ejemplares similares
-
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
por: Beraza-Millor, Marina, et al.
Publicado: (2023) -
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease
por: Rodríguez-Castejón, Julen, et al.
Publicado: (2022) -
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2014) -
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
por: Rodríguez-Castejón, Julen, et al.
Publicado: (2021) -
Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives
por: Torrecilla, Josune, et al.
Publicado: (2014)